Giancarlo Ripabelli
13PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Mar 23, 2026
From Evidence to Implementation: A SIMPIOS Multimodal, Continuous Improvement Approach to Prevent Surgical Site Infections.Massimo Sartelli, Francesco M Labricciosa, Maria Luisa Moro
|Oct 29, 2025
Optimizing Surgical Antibiotic Prophylaxis in the Era of Antimicrobial Resistance: A Position Paper from the Italian Multidisciplinary Society for the Prevention of Healthcare-Associated Infections (SIMPIOS).Massimo Sartelli, Francesco M Labricciosa, Beatrice Casini
|Jan 19, 2023
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Author's reply to correspondence.Giancarlo Ripabelli, Angelo Salzo, Manuela Tamburro
|Oct 31, 2022
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Results from an active pharmacovigilance study in central Italy.Giancarlo Ripabelli, Michela Lucia Sammarco, Antonio D'Amico
|Jun 24, 2022
A Cross-Sectional Study of Untoward Reactions Following Homologous and Heterologous COVID-19 Booster Immunizations in Recipients Seventeen Years of Age and Older.Manuela Tamburro, Giancarlo Ripabelli, Antonio D'Amico
|Mar 25, 2022
A SARS-CoV-2 Outbreak Among Nursing Home Residents Vaccinated with a Booster Dose of mRNA COVID-19 Vaccine.Giancarlo Ripabelli, Michela Lucia Sammarco, Giovanni Rezza
Pageof 3
